Brief: ProQR Therapeutics Files Prospectus Relates To Resale Of Up To 13.4 Mln Shares By Selling Shareholders
29/03/2023 21:57
March 29 (Reuters) - ProQR Therapeutics NV PRQR.O :
* PROQR THERAPEUTICS FILES PROSPECTUS RELATES TO RESALE OR
OTHER
DISPOSITION FROM TIME TO TIME OF UP TO 13.4 MILLION ORDINARY
SHARES BY SELLING SHAREHOLDERS
Source text for Eikon: ID:
Further company coverage: PRQR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ProQR Therapeutics NV
See all newsProQR Therapeutics NV reports results for the quarter ended June 30 - Earnings Summary
ProQR Q2 revenue more than doubles
Brief: ProQR Therapeutics Q2 EPS EUR -0.08
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview